3)- Kun Zhang, Hengxing Gao, Mingwei Chen. Association of antihypertensive drugs with COVID-19 outcomes: a drug-target Mendelian randomization study.Frontiers in pharmacology. 2023, 14: 1224737
4)- Min-Woo Song, Wenhao Cui, Chang-Gun Lee, Rihua Cui, Young Ho Son, Young Ha Kim, Yujin Kim, Hae Jin Kim, Sung-E Choi, Yup Kang, Tae Ho Kim, Ja Young Jeon, Kwan-Woo Lee. Protective effect of empagliflozin against palmitate-induced lipotoxicity through AMPK in H9c2 cells.Frontiers in pharmacology. 2023, 14: 1228646
7)- Yi-Hsin Chen, Chih-Tsung Chen, Han-Ping Wu. Effect of Danshen for improving clinical outcomes in patients with bladder cancer: a retrospective, population-based study.Frontiers in pharmacology. 2023, 14: 1260683
8)- Tesfay Mehari Atey, Gregory M Peterson, Mohammed S Salahudeen, Tom Simpson, Camille M Boland, Ed Anderson, Barbara C Wimmer. Clinical and economic impact of partnered pharmacist medication charting in the emergency department.Frontiers in pharmacology. 2023, 14: 1273657
9)- Eric Fordjour, Charles F Manful, Rabia Javed, Lakshman W Galagedara, Chad W Cuss, Mumtaz Cheema, Raymond Thomas. Chaga mushroom: a super-fungus with countless facets and untapped potential.Frontiers in pharmacology. 2023, 14: 1273786
10)- Mrittika Roy, Shaifali Saroha, Uddipan Sarma, Harini Sarathy, Rukmini Kumar. Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease.Frontiers in pharmacology. 2023, 14: 1274490
11)- Liangtao Wen, Lixiang Xie, Fengying Gong, Shunan Zhang, Tieju Xi. Efficacy and safety of Chinese medicine injections in combination with docetaxel and cisplatin for non-small cell lung cancer: a network meta-analysis.Frontiers in pharmacology. 2023, 14: 1277284
12)- Huqun Li, Chongshu Wang, Aiping Deng, Cuilian Guo. A real-world disproportionality analysis of mepolizumab based on the FDA adverse event reporting system.Frontiers in pharmacology. 2023, 14: 1280490
13)- Jia-Jia Huang, Ji-Zhen Cai, Zhi-Peng Zhou, Yan Liu, Zhen-Jia Yang, Da-Zheng Li, Yu-Hua Chen, Ying-Yi Luan, Yong-Ming Yao, Ming Wu. Impact of early heparin therapy on outcomes in patients with solid malignancy associated sepsis: a marginal structural model causal analyse.Frontiers in pharmacology. 2023, 14: 1281235
14)- Getnet Tadege, Betelhem Sirak, Dehnnet Abebe, Dejen Nureye. Antinociceptive and antiinflammatory activities of crude leave extract and solvent fractions of Hochst. ex C.B.Clarke (Commelinaceae) leaves in murine model.Frontiers in pharmacology. 2023, 14: 1284087
15)- Xue Zhong, Chao Wang, Lin Huang, Yue Zhao, Tianyi Li, Jing He, Xiaohong Zhang. Evaluation of the efficacy and safety of nirmatrelvir/ritonavir co-administration inpatients with rheumatic disease infected with SARS-CoV-2: a real-world study.Frontiers in pharmacology. 2023, 14: 1288402
16)- Siti Liyana Saud Gany, Kok-Yong Chin, Jen Kit Tan, Amilia Aminuddin, Suzana Makpol. Preventative and therapeutic potential of tocotrienols on musculoskeletal diseases in ageing.Frontiers in pharmacology. 2023, 14: 1290721
17)- Susanne Jacobsson, Daniel Golparian, Joakim Oxelbark, Fabian Y S Kong, Renata Maria Augusto Da Costa, Francois Franceschi, David Brown, Arnold Louie, George Drusano, Magnus Unemo. Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against in a gonococcal hollow-fiber infection model.Frontiers in pharmacology. 2023, 14: 1291885
18)- Ni Zhou, Shanshan Wei, Taoli Sun, Suifen Xie, Jian Liu, Wenqun Li, Bikui Zhang. Recent progress in the role of endogenous metal ions in doxorubicin-induced cardiotoxicity.Frontiers in pharmacology. 2023, 14: 1292088
19)- Leonie Zurfluh, Marialuigia Giovannini Spinelli, Cornelia Betschart, Ana Paula Simões-Wüst. Repurposing of for dysmenorrhea treatment: a systematic scoping review and case series.Frontiers in pharmacology. 2023, 14: 1292919
20)- Jacqueline Knapke, Michelle Marcum, Angela Mendell, Patrick Ryan. Development of an undergraduate certificate in clinical and translational science: improving competence of the clinical research workforce.Frontiers in pharmacology. 2023, 14: 1294534
21)- Amin Yakubov, Dina Pimenova, Alzahraa Ahmed, Romelia Corvacho, Joanna Madigan, Jay Naik, Chen Lyu, Anita McFarlane, Victoria Foster, Megan Haseltine, Alexandr Trifonov, Ivette Cabrera, Clarissa Rios, Rachel Gross, Melanie Jay, Aaron Lord, Gabrielle Gold-von Simson, Brita Roy, Amy Freeman, Nadia Islam, James Holahan. The development of a clinical research educational training for community health workers using the joint task force for clinical trial competency framework.Frontiers in pharmacology. 2023, 14: 1295281
22)- Qian Chen, Qingqing Wu, Rong Song, Yating Wang, Mengqi Zhang, Fangqiong Li, Weifang Zeng, Wei Wang, Jingying Jia, Chen Yu, Yanmei Liu. A phase I study to evaluate the safety, tolerability, and pharmacokinetics of a novel, potent GABA analog HSK16149 in healthy Chinese subjects.Frontiers in pharmacology. 2023, 14: 1296672
24)- Alessia Greco, Francesca Coperchini, Laura Croce, Flavia Magri, Marsida Teliti, Mario Rotondi. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs.Frontiers in pharmacology. 2023, 14: 1303844
25)- Judong Kim, Fei Qiao, Avtar K Singh, Jeseong Won, Inderjit Singh. Efficacies of S-nitrosoglutathione (GSNO) and GSNO reductase inhibitor in SARS-CoV-2 spike protein induced acute lung disease in mice.Frontiers in pharmacology. 2023, 14: 1304697
26)- Sandra Truong, Poonam Mudgil. The antibacterial effectiveness of lavender essential oil against methicillin-resistant : a systematic review.Frontiers in pharmacology. 2023, 14: 1306003
27)- Zhenyu Liu, Kexin Yin, Huiqian Liu, Ning Wang, Junjie Yao, Jiangtao Zhou, Yongxi Tang, Zhikang Yin. Comparison of a novel tablet formulation of tacrolimus and conventional capsule formulation in kidney transplant recipients: a systematic review and meta-analysis.Frontiers in pharmacology. 2023, 14: 1310339
29)- Awaji Y Safhi, Nimbagal Raghavendra Naveen, Krishna Jayanth Rolla, Penmetsa Durga Bhavani, Mallesh Kurakula, Khaled M Hosny, Walaa A Abualsunun, Mohammed Alissa, Abdullah Alsalhi, Amerh Aiad Alahmadi, Khalid Zoghebi, Abdulrahman Sindam Halwaani, Rasha Ibrahim K. Enhancement of antifungal activity and transdermal delivery of 5-flucytosine via tailored spanlastic nanovesicles: statistical optimization, characterization, and biodistribution study.Frontiers in pharmacology. 2023, 14: 1321517
30)- Alan Jhones Barbosa Assis, Brunna Letícia de Oliveira Santana, Ana Cristina Moura Gualberto, Fabio Pittella-Silva. Therapeutic applications of CRISPR/Cas9 mediated targeted gene editing in acute lymphoblastic leukemia: current perspectives, future challenges, and clinical implications.Frontiers in pharmacology. 2023, 14: 1322937
32)- Hamid Saeed Shah, Sumera Zaib, Imtiaz Khan, Mahmoud A Sliem, Osama Alharbi, Mohammed Al-Ghorbani, Zobia Jawad, Kiran Shahzadi, Sajjad Awan. Preparation and investigation of a novel combination of loaded, arabinoxylan-cross-linked β-cyclodextrin nanosponges for the treatment of cancer: , , and evaluation.Frontiers in pharmacology. 2023, 14: 1325498
33)- Zhenglin He, Yihan Wang, Liang Han, Yue Hu, Xianling Cong. The mechanism and application of traditional Chinese medicine extracts in the treatment of lung cancer and other lung-related diseases.Frontiers in pharmacology. 2023, 14: 1330518
34)- Jin Xiao, Yan-Ni Zhou, Yan-Lin Yang, Li He, Ke-Kai Wang, Min Chen. Corrigendum: Study on the pathogenesis of MiR-6324 regulating diarrheal irritable bowel syndrome and bioinformatics analysis.Frontiers in pharmacology. 2023, 14: 1330698
36)- Serena Di Vincenzo, Maria Ferraro, Maria Letizia Manca, Josè Esteban Peris, Elisabetta Pace. Editorial: Novel therapeutic strategies for the treatment of respiratory diseases.Frontiers in pharmacology. 2023, 14: 1340116
37)- Giada Crescioli, Niccolò Lombardi, Alfredo Vannacci. Editorial: Safety of drugs and CAM products in pregnancy and breastfeeding: evidence from clinical toxicology.Frontiers in pharmacology. 2023, 14: 1340283
39)- Paola Patrignani, Nils Helge Schebb, Oliver Werz, Dieter Steinhilber. Editorial: Lipidomics of oxylipins in biological systems.Frontiers in pharmacology. 2023, 14: 1342596
40)- Andrea Cruz, Elisabete Fernandes, Raquel O Rodrigues, Susana O Catarino, Diana Pinho. Editorial: Disease-on-a-chip: from point-of-care to personalized medicine.Frontiers in pharmacology. 2023, 14: 1344379
41)- . Retraction: Berberine maintains the neutrophil N1 phenotype to reverse cancer cell resistance to doxorubicin.Frontiers in pharmacology. 2023, 14: 1349235